about
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaAdjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrixRecapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibitionEvaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.Pediatric ependymoma: biological perspectives.Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic responseHighlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursCellular immortality in brain tumours: an integration of the cancer stem cell paradigm.Histone deacetylase inhibition as an anticancer telomerase-targeting strategy.Expression alterations define unique molecular characteristics of spinal ependymomasmicroRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymomaThe Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche.Biomaterial-based local drug delivery to brain tumors.Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growthModulating autophagy as a therapeutic strategy for the treatment of paediatric high-grade gliomaAmplification-free and direct fluorometric determination of telomerase activity in cell lysates using chimeric DNA-templated silver nanoclustersOverall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste
P50
Q24646111-4856AE5C-F7A8-4C94-9272-1C4A240AF315Q27303877-81E6DE96-99A4-4B10-BDD8-3A2933ED1F25Q28484418-ADA86192-3285-4561-8D67-B4420CA627C5Q33771688-26F6C78E-5911-486A-A68D-7654A8B6A354Q34399645-B289B83C-0A44-432F-AAB0-8639500C1F1CQ34987227-298C2EDD-76C8-41A3-80F5-9E5037EBC6A6Q36355916-F1F41D3C-D7AA-421A-BCB8-1D577F390E2EQ36756026-ADC2C595-FC98-49AF-BB9C-C553C5537CD6Q37472314-A0F446B6-4615-444D-9E1C-3E366D8F076DQ37889246-27828CAB-65C6-4CB8-A45D-5D420B1E7990Q41018921-C9027337-E17E-4CFF-A54F-36BF133E66E0Q42562689-43803C31-59AB-40A5-94A8-EE6B7D495636Q47104101-3B6BD297-4507-4F75-B76A-9B456229794FQ47133760-EFF37AD4-0495-4009-835A-FD754D6944B0Q48403397-1FCB0D2F-381B-4EAB-861C-B61A0FFCAB40Q79206557-84EF4056-2B60-4DE8-9E21-582BF56F7D99Q90224559-970A01E5-9BAC-48EE-9679-C9989743389CQ90975040-E1EF2BC0-854B-4C0D-99AC-B5D51A0D589BQ92197966-1B3C4834-63B4-4F0E-9367-56A9E624CB6C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ruman Rahman
@ast
Ruman Rahman
@en
Ruman Rahman
@es
Ruman Rahman
@nl
Ruman Rahman
@sl
type
label
Ruman Rahman
@ast
Ruman Rahman
@en
Ruman Rahman
@es
Ruman Rahman
@nl
Ruman Rahman
@sl
prefLabel
Ruman Rahman
@ast
Ruman Rahman
@en
Ruman Rahman
@es
Ruman Rahman
@nl
Ruman Rahman
@sl
P106
P31
P496
0000-0002-6541-9983